Financials: Bristol-Myers Squibb Company (BMY)

BMY on New York Consolidated

24.25USD
9 Feb 2010
Price Change (% chg)

$0.29 (+1.21%)
Prev Close
$24.25
Open
--
Day's High
$24.30
Day's Low
$23.76
Volume
9,905,306
Avg. Vol
14,284,917
52-wk High
$26.62
52-wk Low
$17.23

view financials for:

Revenue

Earnings Per Share

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-10 11 4,713.01 4,900.00 4,550.00 --
Quarter Ending Jun-10 11 4,945.43 5,000.00 4,873.00 --
Year Ending Dec-10 15 19,967.50 20,325.00 19,602.90 23,265.30
Year Ending Dec-11 14 20,995.00 21,680.00 19,955.00 24,578.30
EARNINGS (per share)
Quarter Ending Mar-10 13 0.53 0.57 0.49 --
Quarter Ending Jun-10 11 0.57 0.59 0.54 --
Year Ending Dec-10 17 2.21 2.30 2.14 2.23
Year Ending Dec-11 16 2.45 2.62 2.15 2.53
LT Growth Rate (%) 7 4.96 12.50 -2.00 9.59

Sales and Earnings Figures in U.S. Dollars (USD)

Valuation Ratios

  Company Industry Sector S&P 500
P/E Ratio (TTM) 14.95 6.43 3.76 14.59
P/E High - Last 5 Yrs. NA 0.87 1.59 16.18
P/E Low - Last 5 Yrs. NA 0.39 0.55 4.36
Beta 0.69 0.71 0.65 1.33
Price to Sales (TTM) 2.52 1.42 1.22 2.01
Price to Book (MRQ) -- 2.16 1.99 2.58
Price to Tangible Book (MRQ) -- 2.25 3.19 5.66
Price to Cash Flow (TTM) -- 4.22 2.07 7.12
Price to Free Cash Flow (TTM) -- 19.66 24.92 12.79
% Owned Institutions -- -- -- --

Dividends

  Company Industry Sector S&P 500
Dividend Yield 5.34 0.89 0.29 1.71
Dividend Yield - 5 Year Avg. 4.73 1.57 1.60 2.35
Dividend 5 Year Growth Rate 2.22 9.24 15.63 -5.31
Payout Ratio(TTM) -- 11.19 4.46 24.71

Growth Rates

  Company Industry Sector S&P 500
Sales (MRQ) vs Qtr. 1 Yr. Ago 10.81 15.76 6.84 10.73
Sales (TTM) vs TTM 1 Yr. Ago 6.17 3.90 1.90 -4.74
Sales - 5 Yr. Growth Rate -0.60 6.42 8.05 7.42
EPS (MRQ) vs Qtr. 1 Yr. Ago -27.61 58.37 142.38 98.28
EPS (TTM) vs TTM 1 Yr. Ago 18.84 -- -- --
EPS - 5 Yr. Growth Rate 5.79 6.61 5.61 8.85
Capital Spending - 5 Yr. Growth Rate -- 4.77 6.95 5.91

Financial Strength

  Company Industry Sector S&P 500
Quick Ratio (MRQ) -- 2.39 2.57 0.81
Current Ratio (MRQ) -- 3.00 3.05 0.95
LT Debt to Equity (MRQ) -- 21.44 25.13 127.01
Total Debt to Equity (MRQ) -- 25.97 32.96 179.52
Interest Coverage (TTM) -- 6.95 3.69 11.83

Profitability Ratios

  Company Industry Sector S&P 500
Gross Margin (TTM) 72.67 31.44 12.78 31.64
Gross Margin - 5 Yr. Avg. 69.30 47.54 56.69 29.11
EBITD Margin (TTM) -- -- -- --
EBITD - 5 Yr. Avg -- 17.37 16.23 15.13
Operating Margin (TTM) 29.79 10.65 -4.90 --
Operating Margin - 5 Yr. Avg. 22.29 15.22 12.24 17.30
Pre-Tax Margin (TTM) 29.79 11.05 -4.88 12.47
Pre-Tax Margin - 5 Yr. Avg. 22.29 15.79 14.23 16.97
Net Profit Margin (TTM) 23.50 9.00 -5.71 9.80
Net Profit Margin - 5 Yr. Avg. 17.53 11.97 7.73 12.33
Effective Tax Rate (TTM) 21.10 7.14 3.58 14.83
Effecitve Tax Rate - 5 Yr. Avg. 21.33 17.07 34.40 26.46

Efficiency

  Company Industry Sector S&P 500
Revenue/Employee (TTM) -- 4,863,234 1,282,917 299,091
Net Income/Employee (TTM) -- 887,247 213,959 26,863
Receivable Turnover (TTM) -- 1.70 0.89 8.07
Inventory Turnover (TTM) -- 0.73 0.64 5.03
Asset Turnover (TTM) -- 0.23 0.12 0.44

Management Effectiveness

  Company Industry Sector S&P 500
Return on Assets (TTM) -- 4.75 1.78 4.25
Return on Assets - 5 Yr. Avg. -- 7.47 6.74 4.83
Return on Investment (TTM) -- 5.95 2.30 5.67
Return on Investment - 5 Yr. Avg. -- 9.43 8.69 6.33
Return on Equity (TTM) -- 8.98 2.82 12.56
Return on Equity - 5 Yr. Avg. -- 11.96 10.04 12.84
  1 Year 3 Years 5 Years
Sales % 6.17 5.08 -0.60
EPS % 19.10 37.36 5.79
Dividend % 0.81 3.73 2.22
Note: Units in Millions of US Dollars

Performance for Bristol-Myers Squibb Company

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -4.47 3.69 94 62
13 Week 3.95 7.52 99 61
26 Week 9.51 4.36 99 66
52 Week 3.86 -14.63 53 18
YTD -5.11 0.13 58 46
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 84.57%
# of Holders: 1,366
Total Shares Held: 1,447,569,342
3 Mo. Net Change: 42,964,798
# New Positions: 31
# Closed Positions: 24
# Increased Positions: 168
# Reduced Positions: 270
# Net Buyers: -102
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
view financials for: